[HTML][HTML] Treatment of brain disease in the mucopolysaccharidoses

M Scarpa, PJ Orchard, A Schulz, PI Dickson… - Molecular genetics and …, 2017 - Elsevier
The mucopolysaccharidosis (MPS) disorders are a group of lysosomal storage diseases
caused by lysosomal enzyme deficits that lead to glycosaminoglycan accumulation, affecting …

Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches

A Fraldi, M Serafini, NC Sorrentino, B Gentner… - Italian journal of …, 2018 - Springer
Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a
deficiency in lysosomal enzymes catalyzing the stepwise degradation of …

[HTML][HTML] Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice

K Whittemore, A Derevyanko, P Martinez… - Aging (Albany …, 2019 - ncbi.nlm.nih.gov
Neurodegenerative diseases associated with old age such as Alzheimer's disease present
major problems for society, and they currently have no cure. The telomere protective caps at …

Understanding and tackling immune responses to adeno-associated viral vectors

H Costa-Verdera, C Unzu, E Valeri, S Adriouch… - Human Gene …, 2023 - liebertpub.com
As the clinical experience in adeno-associated viral (AAV) vector-based gene therapies is
expanding, the necessity to better understand and control the host immune responses is …

Humoral immune responses to AAV gene therapy in the ocular compartment

M Whitehead, A Osborne, P Yu‐Wai‐Man… - Biological …, 2021 - Wiley Online Library
Viral vectors can be utilised to deliver therapeutic genes to diseased cells. Adeno‐
associated virus (AAV) is a commonly used viral vector that is favoured for its ability to infect …

Cell-mediated immunity to AAV vectors, evolving concepts and potential solutions

E Basner-Tschakarjan, F Mingozzi - Frontiers in immunology, 2014 - frontiersin.org
Adeno-associated virus (AAV) vectors are one of the most efficient in vivo gene delivery
platforms. Over the past decade, clinical trials of AAV vector-mediated gene transfer led to …

Advances in diagnostic and treatment modalities for intracranial tumors

PJ Dickinson - Journal of veterinary internal medicine, 2014 - Wiley Online Library
Intracranial neoplasia is a common clinical condition in domestic companion animals,
particularly in dogs. Application of advances in standard diagnostic and therapeutic …

Liver induced transgene tolerance with AAV vectors

GD Keeler, DM Markusic, BE Hoffman - Cellular immunology, 2019 - Elsevier
Immune tolerance is a vital component of immunity, as persistent activation of immune cells
causes significant tissue damage and loss of tolerance leads to autoimmunity. Likewise …

Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease

J Hordeaux, L Dubreil, C Robveille, J Deniaud… - Acta Neuropathologica …, 2017 - Springer
Pompe disease is a lysosomal storage disorder caused by acid-α-glucosidase (GAA)
deficiency, leading to glycogen storage. The disease manifests as a fatal cardiomyopathy in …

AAVrh10 gene therapy ameliorates central and peripheral nervous system disease in canine globoid cell leukodystrophy (Krabbe disease)

AM Bradbury, MA Rafi, JH Bagel, BK Brisson… - Human Gene …, 2018 - liebertpub.com
Globoid cell leukodystrophy (GLD), or Krabbe disease, is an inherited, neurologic disorder
that results from deficiency of a lysosomal enzyme, galactosylceramidase. Most commonly …